Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
American Journal of Hematology|June 13, 2024
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnanciesNaseema Gangat, Amritpal Singh, Rimal Ilyas, et al.American Journal of Hematology|March 10, 2025
Thrombosis-Driven Disease Progression in JAK2-Mutant Polycythemia Vera and Essential Thrombocythemia: Reassessing Risk-Based ManagementTiziano Barbui, Valerio De Stefano, Elena Rossi, et al.JAMA|January 27, 2025
Essential Thrombocythemia: A ReviewAyalew Tefferi, Naseema Gangat, Giuseppe Gaetano Loscocco, et al.Blood Cancer Journal|February 11, 2022
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia veraAlessandra Carobbio, Alessandro Maria Vannucchi, Valerio De Stefano, et al.British Journal of Haematology|October 8, 2024
Neutrophil/lymphocyte ratio identifies low-risk polycythaemia vera patients for early Ropeginterferon alfa-2b therapyTiziano Barbui, Alessandra Carobbio, Paola Guglielmelli, et al.Haematologica|April 9, 2026
Changes in neutrophil-to-lymphocyte ratio in patients with polycythemia vera treated with ruxolitinib reflect JAK2 variant allele frequencyPaola Guglielmelli, Chiara Paoli, Giulia Borgi, et al.Leukemia|February 20, 2026
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy imagesAndrew Srisuwananukorn, Giuseppe Gaetano Loscocco, James M Dolezal, et al.Cancers|August 12, 2023
Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential DiagnosesMagda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, et al.Blood Cancer Journal|August 6, 2025
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia veraTiziano Barbui, Arianna Ghirardi, Victoria Empson, et al.Blood|January 22, 2024
CALR mutation burden in essential thrombocythemia and disease outcomePaola Guglielmelli, Natasha Szuber, Naseema Gangat, et al.Pageof 2